Ratio of tax provision to profit before tax for public limited companies in the pharmaceuticals industry for the 2016-17 fiscal year

Annual · percent · 2014–2016 · Published by India — Reserve Bank of India

Latest · 2016

17.1%

down −0.8 pts vs 2015

High since 2014
20.1% · 2014
Low since 2014
17.1% · 2016

percent

Use this series in your AI

Use FactIQ to chart rbi::rbi|03900f537f1d924b over the last ten years, with its latest value and the change over the past year.

Paste into an AI model with FactIQ connected. How to connect

About this series

This series represents the percentage of profit before tax that was set aside for tax provisions by non-government non-financial public limited companies within the pharmaceuticals sector. The data is based on Statement 12 of the Select Financial Ratios and specifically covers the historical reference period of the 2016-17 fiscal year. (Footnote: *=actual ratio; ^=average assets; **=profit-making-company subset; @=two-year-difference derived metric; # and -=missing token; row_markers=**)

Series ID
rbi::rbi|03900f537f1d924b
Frequency
Annual
Units
percent
Coverage
2014 – 2016
Ratio of tax provision to profit before tax for public limited companies in the pharmaceuticals industry for the 2016-17 fiscal year: 17.1% for 2016 · FactIQ